ANA MARÍA
IGLESIAS PÉREZ
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (1)
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433